Application Note: Developing revolutionary new drugs from monoclonal antibodies that target GPCRs
5 June 2020

Find out how Dr. Kiyoshi Takayama, President of NB Health Laboratory, is using the Intellicyt iQue3 to develop revolutionary new drugs from mAbs that target G-protein coupled receptors (GPCRs).